Pfizer
Nominated for Foreign Investor of the Year 2023
Based in Flanders, Pfizer Puurs is one of Pfizer’s largest manufacturing and packaging units worldwide and the largest vaccine plant in the world. Annually, they produce 400 million units of sterile injectable medicines and vaccines (excluding COVID-19 vaccines).
In late 2022, Pfizer Puurs announced a new investment project on three fronts: more production capacity, additional cold storage capability and enhanced packaging lines. This investment dedication highlights how the American pharmaceutical giant, which is already deeply embedded in the local ecosystem, wants to anchor itself even more firmly in Flanders.
The medicines and vaccines produced by Pfizer in Puurs are exported from the Flanders-based site to more than 170 countries, boosting Flanders’ export figures in the process. Moreover, 30% of exports from Puurs go to low- and middle-income countries, in cooperation with non-profit organizations.
ID Pfizer
-
Type of investment: expansion project
-
Investment location: Puurs
-
Investment amount: € 1.2 billion (over 3 years)
-
Job creation in Flanders: 250 jobs
Picture: Communication Specialist Wouter Ollevier and Managing Director Luc Van Steenwinkel, Pfizer